The Utilization and Outcomes of Inferior Vena Cava Filter Use

Objective The utilization of inferior vena cava filters (IVCF) has evolved over time. We explored the indications, complications, and outcomes of patients undergoing IVCF placement. Methods We performed a single institution, retrospective review of CPT codes for IVCF placement between 2018 and 2022....

Full description

Saved in:
Bibliographic Details
Main Authors: Krystina N Choinski MD, Jason Storch MD, Simeret Genet BS, MA, Maximillian Bazil BS, Jonathan Joasil BS, Rodnell Busigo Torres BS, Kennedy Salamat BS, Akila Pai MD, Christopher J Smolock MD, John Phair MD
Format: Article
Language:English
Published: SAGE Publishing 2025-07-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296251338234
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849303919081029632
author Krystina N Choinski MD
Jason Storch MD
Simeret Genet BS, MA
Maximillian Bazil BS
Jonathan Joasil BS
Rodnell Busigo Torres BS
Kennedy Salamat BS
Akila Pai MD
Christopher J Smolock MD
John Phair MD
author_facet Krystina N Choinski MD
Jason Storch MD
Simeret Genet BS, MA
Maximillian Bazil BS
Jonathan Joasil BS
Rodnell Busigo Torres BS
Kennedy Salamat BS
Akila Pai MD
Christopher J Smolock MD
John Phair MD
author_sort Krystina N Choinski MD
collection DOAJ
description Objective The utilization of inferior vena cava filters (IVCF) has evolved over time. We explored the indications, complications, and outcomes of patients undergoing IVCF placement. Methods We performed a single institution, retrospective review of CPT codes for IVCF placement between 2018 and 2022. Patient characteristics and location were collected. Indications for IVCF placement were categorized. Procedural details were noted and immediate and long-term complications. IVCF removal, total IVCF days, and removal complication were analyzed. Overall mortality, cause of death, and if death occurred the same admission were included. Results An analysis of 347 patients undergoing IVCF placement was performed. Mean patient age was 65 years-old (+/– 16 years), 167 patients (48%) were male, and 28% with current malignancy at time of IVCF placement. 8% of patients had prior DVT, 22% prior PE, 3% prior IVCF. 84% were inpatient on floors, 12% in the ICU, and 4% ambulatory. IVCF were typically placed prior to a surgery with contraindication to anticoagulation (41%), gastrointestinal bleed (15%), failure of anticoagulation (10%), brain bleed (9%), and during venous thrombectomy (8%). The operations included spine procedures (17%) other orthopedic procedures (19%), abdominal procedures (32%), and bariatric interventions (6%). Retrievable filters were placed in 99% of patients. Immediate postoperative complications occurred in 6% of patients. Worsening edema within the same admission, DVT, and filter strut migration in 12% of patients. 29% of patients underwent IVCF removal, of which 10 were unsuccessful and resulted in the filter remaining in place despite an attempt to retrieve it. All-cause mortality at any time point was 21%, with 42% of mortalities occurring during the same admission as the IVC filter placement. Of these mortalities, 4 (1.2%) were secondary to VTE complications. Mortality at 30 days was 8.3% and at 1 year was 15.7%. Death during the admission of IVC filter placement was positively correlated with older age (p = 0.010) and current malignancy was associated with higher mortality (OR 2.2, p < 0.001). Spine surgery patients were 3.8 times more likely to undergo IVCF removal (p = 0.002) as well as patients undergoing ambulatory IVCF placement (p = 0.001). Conclusion IVCF placement has utility in younger patients undergoing elective operations, particularly spine procedures, with contraindication to anticoagulation. Older patients and those with current malignancy are unlikely to benefit given the higher mortality.
format Article
id doaj-art-7955753dd2a64d72bda0d323d63c2d8a
institution Kabale University
issn 1938-2723
language English
publishDate 2025-07-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj-art-7955753dd2a64d72bda0d323d63c2d8a2025-08-20T03:55:54ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232025-07-013110.1177/10760296251338234The Utilization and Outcomes of Inferior Vena Cava Filter UseKrystina N Choinski MDJason Storch MDSimeret Genet BS, MAMaximillian Bazil BSJonathan Joasil BSRodnell Busigo Torres BSKennedy Salamat BSAkila Pai MDChristopher J Smolock MDJohn Phair MDObjective The utilization of inferior vena cava filters (IVCF) has evolved over time. We explored the indications, complications, and outcomes of patients undergoing IVCF placement. Methods We performed a single institution, retrospective review of CPT codes for IVCF placement between 2018 and 2022. Patient characteristics and location were collected. Indications for IVCF placement were categorized. Procedural details were noted and immediate and long-term complications. IVCF removal, total IVCF days, and removal complication were analyzed. Overall mortality, cause of death, and if death occurred the same admission were included. Results An analysis of 347 patients undergoing IVCF placement was performed. Mean patient age was 65 years-old (+/– 16 years), 167 patients (48%) were male, and 28% with current malignancy at time of IVCF placement. 8% of patients had prior DVT, 22% prior PE, 3% prior IVCF. 84% were inpatient on floors, 12% in the ICU, and 4% ambulatory. IVCF were typically placed prior to a surgery with contraindication to anticoagulation (41%), gastrointestinal bleed (15%), failure of anticoagulation (10%), brain bleed (9%), and during venous thrombectomy (8%). The operations included spine procedures (17%) other orthopedic procedures (19%), abdominal procedures (32%), and bariatric interventions (6%). Retrievable filters were placed in 99% of patients. Immediate postoperative complications occurred in 6% of patients. Worsening edema within the same admission, DVT, and filter strut migration in 12% of patients. 29% of patients underwent IVCF removal, of which 10 were unsuccessful and resulted in the filter remaining in place despite an attempt to retrieve it. All-cause mortality at any time point was 21%, with 42% of mortalities occurring during the same admission as the IVC filter placement. Of these mortalities, 4 (1.2%) were secondary to VTE complications. Mortality at 30 days was 8.3% and at 1 year was 15.7%. Death during the admission of IVC filter placement was positively correlated with older age (p = 0.010) and current malignancy was associated with higher mortality (OR 2.2, p < 0.001). Spine surgery patients were 3.8 times more likely to undergo IVCF removal (p = 0.002) as well as patients undergoing ambulatory IVCF placement (p = 0.001). Conclusion IVCF placement has utility in younger patients undergoing elective operations, particularly spine procedures, with contraindication to anticoagulation. Older patients and those with current malignancy are unlikely to benefit given the higher mortality.https://doi.org/10.1177/10760296251338234
spellingShingle Krystina N Choinski MD
Jason Storch MD
Simeret Genet BS, MA
Maximillian Bazil BS
Jonathan Joasil BS
Rodnell Busigo Torres BS
Kennedy Salamat BS
Akila Pai MD
Christopher J Smolock MD
John Phair MD
The Utilization and Outcomes of Inferior Vena Cava Filter Use
Clinical and Applied Thrombosis/Hemostasis
title The Utilization and Outcomes of Inferior Vena Cava Filter Use
title_full The Utilization and Outcomes of Inferior Vena Cava Filter Use
title_fullStr The Utilization and Outcomes of Inferior Vena Cava Filter Use
title_full_unstemmed The Utilization and Outcomes of Inferior Vena Cava Filter Use
title_short The Utilization and Outcomes of Inferior Vena Cava Filter Use
title_sort utilization and outcomes of inferior vena cava filter use
url https://doi.org/10.1177/10760296251338234
work_keys_str_mv AT krystinanchoinskimd theutilizationandoutcomesofinferiorvenacavafilteruse
AT jasonstorchmd theutilizationandoutcomesofinferiorvenacavafilteruse
AT simeretgenetbsma theutilizationandoutcomesofinferiorvenacavafilteruse
AT maximillianbazilbs theutilizationandoutcomesofinferiorvenacavafilteruse
AT jonathanjoasilbs theutilizationandoutcomesofinferiorvenacavafilteruse
AT rodnellbusigotorresbs theutilizationandoutcomesofinferiorvenacavafilteruse
AT kennedysalamatbs theutilizationandoutcomesofinferiorvenacavafilteruse
AT akilapaimd theutilizationandoutcomesofinferiorvenacavafilteruse
AT christopherjsmolockmd theutilizationandoutcomesofinferiorvenacavafilteruse
AT johnphairmd theutilizationandoutcomesofinferiorvenacavafilteruse
AT krystinanchoinskimd utilizationandoutcomesofinferiorvenacavafilteruse
AT jasonstorchmd utilizationandoutcomesofinferiorvenacavafilteruse
AT simeretgenetbsma utilizationandoutcomesofinferiorvenacavafilteruse
AT maximillianbazilbs utilizationandoutcomesofinferiorvenacavafilteruse
AT jonathanjoasilbs utilizationandoutcomesofinferiorvenacavafilteruse
AT rodnellbusigotorresbs utilizationandoutcomesofinferiorvenacavafilteruse
AT kennedysalamatbs utilizationandoutcomesofinferiorvenacavafilteruse
AT akilapaimd utilizationandoutcomesofinferiorvenacavafilteruse
AT christopherjsmolockmd utilizationandoutcomesofinferiorvenacavafilteruse
AT johnphairmd utilizationandoutcomesofinferiorvenacavafilteruse